BCL-6 expression during B-cell activation

Blood

Volumn 87, Issue 12, 1996, Pages 5257-5268

  Allman, David ^b   Jain, Ashish ^b   Dent, Alex ^b   Maile, Randal R ^b   Selvaggi, Thomas ^b   Kehry, Marilyn R ^b   Staudt, Louis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD40 ANTIGEN; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE TRANSLOCATION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029904294     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5257.bloodjournal87125257     Document Type: Article

References (55)

1. Baron BW, Nucifora G, McCabe N, Espinosa RI, LeBeau MM, McKeithan TW: Identification of the gene associated with the recurring chromosomal translocations t(3; 14)(q27;q23) and t(3;22) (q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262, 1993
2. Miki T, Kawamata N, Hirosawa S, Aoki N: Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a krüppel-like zinc-finger protein. Blood 83:26, 1994
3. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747, 1993
4. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C: LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5:66, 1993
5. Magrath IT: The Non-Hodgkin's lymphomas: an introduction, in Magrath IT (ed): The Non-Hodgkin's Lymphomas. London, UK, Arnold, 1990, p 1
6. LoCoco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RSK, Dalla-Favera R: Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757, 1994
7. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Peaaella F, Fruchart C, Duval C, Monconduit M, Tilly H: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423, 1994
8. Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, Raffeld M: Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 85:2877, 1995
9. Gaidano G, LoCoco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood 84:397, 1994
10. Offit K, LoCoco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74, 1994
11. Bardwell VJ, Treisman R: The POZ domain: A conserved protein-protein interaction motif. Genes Dev 8:1664, 1994
12. Cattoretti G, Chang C-C, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: Bcl-6 protein is expressed in germinal-center B cells. Blood 86:45, 1995
13. Onizuka T, MMoriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H, Mori S: Bcl-6 gene product, a 92- to 98kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 86:28, 1995
14. Flenghi L, Ye BH, Fizzotti M, Bigerna B, Cattoretti G, Venturi S, Pacini R, Pileri S, Lo Coco F, Pescarmona E, Pelicci P-G, Dalla-Favera R, Falini B: A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 147:405, 1995
15. Staudt LM, Dent A, Ma C, Allman D, Powell J, Maile R, Scherle P, Behrens T: Rapid indentification of novel human lymphoid-restricted genes by automated DNA sequencing of subtracted cDNA libraries. Curr Top Microbiol Immunol 194:155, 1994
16. hi and exhibit unique signaling properties. J Immunol 149:2533, 1992
17. Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB: Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation. Eur J Immunol 20:201, 1990
18. Liu Y-J, Banchereau J: Human peripheral B cell subsets, in Weir D, Blackwell C, Herzenberg L, Herzenberg L (eds): Handbook of Expimental Immunology (ed 5). Oxford, UK, Blackwell Scientific (in press)
19. Irving SG, June CH, Zipfel PF, Siebenlist U, Kelly K: Mitogen-induced genes are subject to multiple pathways of regulation in the initial stages of T-cell activation. Mol Cell Biol 9:1034, 1989
20. Seyfert VL, McMahon S, Glenn W, Cao X, Sukhatme VP, Monroe JG: Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation. J Immunol 145:3647, 1990
21. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology, vol 1. New York, Green Publishing and Wiley-Interscience, 1993
22. Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K: Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 155:2369, 1995
23. O'Reilly DR, Miller LK, Luckow VA: Baculovirus expression vectors, a laboratory manual. New York, NY, Freeman, 1992
24. Kehry MR, Castle BE: Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin Immunol 6:287, 1994
25. Hodgkin PD, Yamashita LC, Coffman RL, Kehry MR: Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J Immunol 145:2025, 1990
26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
27. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431, 1985
28. Miki T, Kawamata N, Arai A, Ohashi K, Nakamura Y, Kato A, Hirosawa S, Aoki N: Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 83:217, 1994
29. Calender A, Billaud M, Aubry JP, Banchereau J, Vuillaume M, Lenoir GM: Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci USA 84:8060, 1987
30. Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E: Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 84:3452, 1987
31. Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E: Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 62:4173, 1988
32. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122, 1992
33. Schittek B, Rajewsky K, Forster I: Dividing cells in bone marrow and spleen incorporate bromodeoxyuridine with high efficiency. Eur J Immunol 21:235, 1991
34. MacLennan ICM: Germinal centers. Annu Rev Immunol 12:117, 1994
35. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791, 1994
36. Hammarskjold ML, Simurda MC: Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J Virol 66:6496, 1992
37. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM: The Epstein-Barr virus LMPI gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267:24157, 1992
38. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
39. Henkel T, Ling PD, Hayward SD, Peterson MG: Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92, 1994
40. Waltzer L, Logeat F, Brou C, Israel A, Sergeant A, Manet E: The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J 13:5633, 1994
41. Yao XR, Scott DW: Inhibition of protein tyrosine kinase activity by herbimycin A prevents anti-mu but not LPS-mediated cell cycle progression and differentiation of splenic B lymphocytes. Cell Immunol 149:364, 1993
42. Liu JL, Chiles TC, Sen RJ, Rothstein TL: Inducible nuclear expression of NF-kappa B in primary B cells stimulated through the surface Ig receptor. J Immunol 146:1685, 1991
43. Sen R, Baltimore D: Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921, 1986
44. Ledbetter JA, Grosmaire LS, Hollenbaugh D, Aruffo A, Nadler SG: Agonistic and antagonistic properties of CD40 mAb G28-5 are dependent on binding valency. Circ Shock 44:67, 1994
45. Francis DA, Karras JG, Ke XY, Sen R, Rothstein TL: Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 7:151, 1995
46. Berberich I, Shu GL, Clark EA: Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol 153:4357, 1994
47. Cheng G, Cleary AM, Ye ZS, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494, 1995
48. Hu HM, O'Rourke K, Boguski MS, Dixit VM: A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069, 1994
49. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G: Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 155:556, 1995
50. Shokat KM, Goodnow CC: Antigen-induced B-cell elimination during germinal-centre immune responses. Nature 375:334, 1995
51. Pulendran B, Kannourakis G, Nouri S, Smith KG, Nossal GJ: Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375:331, 1995
52. Galibert L, van Dooren J, Durand I, Rousset F, Jefferis R, Banchereau J, Lebecque S: Anti-CD40 plus interleukin-4-activated human naive B cell lines express unmutated immunoglobulin genes with intraclonal heavy chain isotype variability. Eur J Immunol 25:733, 1995
53. Klausner RD, Harford JB: Cis-trans models for post-transcriptional gene regulation. Science 246:870, 1989
54. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485, 1995
55. Lin WC, Desiderio S: Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science 260:953, 1993